# Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

> **NCT01494896** · — · TERMINATED · sponsor: **University of Florida** · enrollment: 9 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension
- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01494896
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** due to slow enrollment. United Therapeutics and Dr. Bajwa MD decided to terminate study
- **Last updated:** 2015-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494896, "Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01494896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*